Skip to content
ADAPTILENS ANNOUNCES $17.5M SERIES A FINANCING
  • Home
  • Our Technology
  • Team
  • News
  • Contact
Menu
  • Home
  • Our Technology
  • Team
  • News
  • Contact

In the Media

  • All News
  • In the Media
  • Announcements
  • Publications
Menu
  • All News
  • In the Media
  • Announcements
  • Publications

Adaptilens Featured in C&EN: Celebrating Founder-Led Biotech Innovation

November 13, 2024
Read More »

Dr. Clamen featured in the When Science Speaks podcast

October 22, 2022
Read More »

Dr. Clamen featured in the Amazing Execs episode 102 “Developing a Breakthrough New Ophthalmic Medical Device”

July 26, 2022
Read More »

Adaptilens chosen to participate in Harvard’s highly selective Launch Lab X GEO accelerator

October 25, 2021
Read More »

Adaptilens selected as a finalist for the 2020 MassChallenge Boston program

June 3, 2020
Read More »
Updates
No updates found.
Follow Adaptilens on Linkedin
Adaptilens is made possible with help from​
notice: The Adaptilens is in the development phase and is not yet approved for investigational or commercial use.

Follow our progress on

Linkedin